logo-loader
Kromek Group PLC

Kromek Group PLC - Award of Five-Year Contract from BMD Customer

RNS Number : 2166O
Kromek Group PLC
17 August 2017
 

 

17th August 2017

 

Kromek Group plc

("Kromek" or the "Company")

 

Kromek Awarded Five-Year Contract from Existing BMD Customer  

 

New long-term order from existing BMD customer for use of Kromek's CZT-based detector module in new medical diagnostics product

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, is pleased to announce that it has been awarded a new five-year contract by an existing customer in the bone mineral densitometry ("BMD") sector for the incorporation of its cadmium zinc telluride ("CZT")-based detector modules in a new product. Delivery on the contract, which is worth a minimum value of $5.38m, is expected to begin in the current 2017/18 financial year. 

 

Dr Arnab Basu, CEO of Kromek, said: "We are delighted to have secured a further contract by an existing BMD customer as they launch a new medical diagnostics product. It further validates our belief that, as customers move away from legacy diagnostic systems, CZT based detectors will become a core technology and we anticipate to be one of the major suppliers to this segment. The agreement also demonstrates the strong relationships we build with our customers and the Company's commitment to securing further contracts in the medical imaging sector."

 

 

Enquiries

Kromek Group plc

01740 626 060

Arnab Basu, CEO

Derek Bulmer, CFO




Cenkos Securities plc

020 7397 8900

Bobbie Hilliam (NOMAD)




Luther Pendragon

020 7618 9100

Harry Chathli, Claire Norbury, Alexis Gore






 

 

About Kromek Group plc

 

Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma photon imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

                                                                                   

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

 

 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUNRORBNAWAUR
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

Kromek Group reports strong first-half momentum as revenue and gross margin...

Kromek Group PLC (AIM:KMK) CEO Arnab Basu joined Proactive's Stephen Gunnion with a breakdown of the company's first-half financial and operational performance. The company reported increased revenue, improved gross margin, and a notably reduced loss in the first half of the year. Basu...

on 30/1/24

3 min read